Can inflammation, micronutrient strain, and higher SHBG reduce free androgen availability?

Androgen bioactivity is regulated by a complex network of central signaling, peripheral synthesis, and transport dynamics. Dysregulation across these pathways can significantly compromise circulating free testosterone levels.

HPG axis suppression and inflammation

• Central and peripheral inhibition: Pro-inflammatory cytokines, specifically interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α), directly inhibit hypothalamic gonadotropin-releasing hormone (GnRH) neurons, which blunts luteinizing hormone (LH) pulsatility and pituitary responsiveness.
• Impaired steroidogenesis: Systemic inflammatory mediators directly compromise testicular Leydig cell function, suppressing overall androgen synthesis.

Micronutrient strain and steroidogenesis

• Leydig cell dysfunction: Micronutrient deficiencies, particularly zinc deficiency, impair essential steroidogenic enzymes. This causes Leydig cell failure, restricting testosterone production and potentially leading to testicular atrophy.
• Repletion effects: Clinical zinc repletion has been shown to reverse these deficits, improving total testosterone levels and modulating gonadotropic activity.

Transport kinetics and free androgen bioavailability

• SHBG binding affinity: Sex hormone-binding globulin (SHBG) binds circulating testosterone with high affinity (association constant of approximately 10^9 L/mol), rendering 45% to 55% of total testosterone biologically inert.
• Inflammatory interactions: Although chronic metabolic inflammation (marked by elevated hs-CRP) can suppress hepatic SHBG synthesis, the concurrent reduction in total testosterone synthesis ensures that elevated SHBG concentrations disproportionately deplete the remaining free, biologically active androgen pool.

Bottom line

• Systemic inflammation and zinc deficiency cooperatively suppress HPG axis signaling and Leydig cell steroidogenesis, while high-affinity SHBG binding further restricts the pool of free, biologically active hormone.